Transparency and the Food and Drug AdministrationA Quantitative Study
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Journal of health communication - 18(2013), 4 vom: 1. Apr., Seite 391-396 |
| Beteiligte Personen: |
Lofstedt, Ragnar [VerfasserIn] |
|---|
| Umfang: |
6 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1914664132 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1914664132 | ||
| 003 | DE-627 | ||
| 005 | 20230517190314.0 | ||
| 007 | tu | ||
| 008 | 130318s2013 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw130315_2 |
| 035 | |a (DE-627)OLC1914664132 | ||
| 035 | |a (DE-599)GBVOLC1914664132 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 100 | 1 | |a Lofstedt, Ragnar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Transparency and the Food and Drug AdministrationA Quantitative Study |
| 264 | 1 | |c 2013 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Bouder, Frederic |4 oth | |
| 700 | 1 | |a Chakraborty, Sweta |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of health communication |d London : Taylor & Francis, 1996 |g 18(2013), 4 vom: 1. Apr., Seite 391-396 |w (DE-627)244023255 |w (DE-600)1427988-5 |x 1081-0730 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2013 |g number:4 |g day:1 |g month:04 |g pages:391-396 |g extent:6 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-VOR | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4310 | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2013 |e 4 |b 1 |c 4 |h 391-396 |g 6 | ||